• Medpace held its annual shareholder meeting on May 15, 2026.
• Shareholders backed amendments to the company’s charter to eliminate supermajority voting requirements, with the changes taking effect on May 18, 2026 upon filing.
• They also supported a separate charter amendment removing limits on shareholders calling special meetings, which became effective on May 18, 2026 upon filing.
• The board subsequently amended the bylaws to allow shareholders owning at least 25% of voting power to call a special meeting, subject to notice requirements and a one-year continuous ownership condition.
• A non-binding shareholder proposal seeking the ability to call a special meeting did not pass.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medpace Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-230425), on May 19, 2026, and is solely responsible for the information contained therein.